Senior Research Assistant — miRNA & Circulating Biomarkers (2‑yr Contract)

Times Higher Education; Hong Kong; On-site; HKD 500,000 - 800,000; Full time

Benefits offered by this job

Medical benefits

Retirement benefits (pension)

Job summary

The University of Hong Kong invites applications for a Senior Research Assistant in the Department of Surgery, School of Clinical Medicine. The position is a two-year, full-time appointment with renewal subject to funding and performance.

The appointee will join a team researching cancer development, miRNA regulation, proteomics and circulating biomarkers for diagnosis, prognosis, and metastasis prediction.

Qualifications

• PhD in Biomedical Sciences, Life Sciences, Multi-omics or related discipline with 10+ years of research experience.
• Strong background in miRNA biology, circulating biomarkers, exosomes, and translational cancer research essential.
• At least 5 years of postdoctoral research experience with a strong publication record and conference presentations advantageous.

Responsibilities

• Investigate oncogenic and tumour-suppressor miRNAs and their downstream signalling; study circulating biomarkers for diagnosis, prognosis and metastasis prediction.
• Perform proteomic profiling of oncogenes and tumour suppressors; validate biomarkers for metastasis and clinical outcomes.
• Assist in clinical sample collection/processing, maintain databases/biobanking, support grant writing and manuscript preparation, present findings at meetings.

Skills

miRNA biology

Translational cancer research

Circulating biomarkers

Proteomic profiling

Education

PhD in Biomedical/Life Sciences

Postdoctoral research experience

Job description

The University of Hong Kong invites applications for a Senior Research Assistant in the Department of Surgery, School of Clinical Medicine. The position is a two-year, full-time appointment with renewal subject to funding and performance.

The appointee will join a team researching cancer development, miRNA regulation, proteomics and circulating biomarkers for diagnosis, prognosis, and metastasis prediction.